Growth factor concentrate treatment for hair loss is gaining popularity due to its efficacy in controlling hair loss and promoting hair re-growth. Now several growth factors that can control the development and cycle of the hair follicle have been identified. Some participate in the anagen phase initiation (IGF-1, HGF, KGF, VEGF, FGF-2, FGF-18), while others suppress the growth and differentiation of a follicle in the telogen and catagen phases (TGF-b, FGF-5, EGF). Thus, growth factors can be key molecules that participate in the initiation and suppression of hair growth. The pre-activated growth factor ACD gel has been used in the GFC tubes to add value to the treatment and release the growth factors once the pure platelet with growth factor concentrates is injected and released into the scalp. Thus, we may conclude that the VEGF, KGF, and TGF-beta1 growth factors influence the development of androgenic alopecia in women. Men obviously have other factors prevailing in the pathogenesis of alopecia development. The growth factor concentrate treatment responds well in women with grades 2 and 3 of hair-loss conditions sooner than men, as men with high levels of androgen hormone generation respond to the treatment after 4-6 sessions compared with women who see results in 3-4 sessions. Remember, hair loss doesn’t happen overnight and doesn’t grow back either, so patience and determination, along with a controlled lifestyle and value-based food intake, help control hair loss along with the ongoing GFC treatment. A recent development in the GFC treatment is the introduction of the Fibrin + amalgamation, which is showing a substantial difference in the outcome of the treatment within a few sessions in men, and 1mypro, an emerging brand in Aesthetic machines and products, has introduced innovative GFC treatment and has been practised in leading clinics like Max Hair Clinic, Adgrohair, and many more. Experience innovation by undergoing the GFC Fibrin+ treatment.
